Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $403.51 million. The enterprise value is $149.10 million.

Market Cap	403.51M
Enterprise Value	149.10M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ATXS has 56.43 million shares outstanding. The number of shares has increased by 33.79% in one year.

Current Share Class	56.43M
Shares Outstanding	56.43M
Shares Change (YoY)	+33.79%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	63.78%
Float	34.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	25.25
PB Ratio	2.44
P/TBV Ratio	2.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.89, with a Debt / Equity ratio of 0.02.

Current Ratio	14.89
Quick Ratio	14.36
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -38.49% and return on invested capital (ROIC) is -26.58%.

Return on Equity (ROE)	-38.49%
Return on Assets (ROA)	-25.28%
Return on Invested Capital (ROIC)	-26.58%
Return on Capital Employed (ROCE)	-49.80%
Revenue Per Employee	n/a
Profits Per Employee	-$1.50M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.80% in the last 52 weeks. The beta is 0.42, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-42.80%
50-Day Moving Average	6.85
200-Day Moving Average	6.47
Relative Strength Index (RSI)	50.62
Average Volume (20 Days)	422,316

Short Selling Information

The latest short interest is 2.94 million, so 5.21% of the outstanding shares have been sold short.

Short Interest	2.94M
Short Previous Month	2.79M
Short % of Shares Out	5.21%
Short % of Float	8.52%
Short Ratio (days to cover)	10.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-131.42M
Pretax Income	-116.92M
Net Income	-116.92M
EBITDA	n/a
EBIT	-131.42M
Earnings Per Share (EPS)	-$2.02

Balance Sheet

The company has $259.18 million in cash and $4.77 million in debt, giving a net cash position of $254.41 million or $4.51 per share.

Cash & Cash Equivalents	259.18M
Total Debt	4.77M
Net Cash	254.41M
Net Cash Per Share	$4.51
Equity (Book Value)	260.51M
Book Value Per Share	2.93
Working Capital	250.54M

Cash Flow

In the last 12 months, operating cash flow was -$115.40 million and capital expenditures -$610,000, giving a free cash flow of -$116.01 million.

Operating Cash Flow	-115.40M
Capital Expenditures	-610,000
Free Cash Flow	-116.01M
FCF Per Share	-$2.06

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.79%
Shareholder Yield	-33.79%
Earnings Yield	-28.98%
FCF Yield	-28.75%

Analyst Forecast

The average price target for ATXS is $33.00, which is 361.54% higher than the current price. The consensus rating is "Buy".

Price Target	$33.00
Price Target Difference	361.54%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 1:6.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1